Catherine Mackey J.'s most recent trade in Avid Bioservices Inc was a trade of 26,756 Common Stock, $0.001 par value done . Disclosure was reported to the exchange on Dec. 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Avid Bioservices Inc | Catherine J. Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 26,756 | 43,379 (0%) | 0% | - | Common Stock, $0.001 par value | |
Avid Bioservices Inc | Catherine J. Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 26,756 | 0 | - | - | Restricted Stock Units | |
Avid Bioservices Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2024 | 8,147 | 8,147 | - | - | Restricted Stock Units | |
Voyager Therapeutics Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
Ideaya Biosciences Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
Avid Bioservices Inc | Mackey J. Catherine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 26,756 | 26,756 | - | - | Restricted Stock Units | |
Avid Bioservices Inc | Catherine Mackey J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 9,612 | 0 | - | - | Restricted Stock Units | |
Avid Bioservices Inc | J. Catherine Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 9,612 | 16,623 (0%) | 0% | - | Common Stock, $0.001 par value | |
Ideaya Biosciences Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
Voyager Therapeutics Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
Voyager Therapeutics Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
Ideaya Biosciences Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
Avid Bioservices Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 4,632 | 4,632 | - | - | Restricted Stock Units | |
Avid Bioservices Inc | Catherine J. Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,379 | 2,379 (0%) | 0% | - | Common Stock, $0.001 par value | |
Avid Bioservices Inc | Catherine J. Mackey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,379 | 0 | - | - | Restricted Stock Units | |
Avid Bioservices Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 10,030 | 61,805 | - | - | Stock Option (right to buy) | |
Avid Bioservices Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 2,379 | 2,379 | - | - | Restricted Stock Units | |
Poseida Therapeutics Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |